Press Releases
April 29, 2025
Sumitomo Pharma America Presents New Data on Vibegron at the 2025 American Urological Association Annual Meeting
– Data include results from COURAGE Phase 3 and COMPOSUR Phase 4 studies of vibegron (GEMTESA®) –